Search page

A randomized, double-blind, phase 2a study of covalent Bruton’s tyrosine kinase inhibitor TAS5315 in patients with chronic spontaneous urticaria with an inadequate response to H1-antihistamines

A retrospective analysis of patients with chronic spontaneous urticaria in treatment with Omalizumab conducted in Brescia

Advances in Chronic Urticaria treatment

Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year

Anaphylaxis Induced by Cholinergic Urticaria

Anaphylaxis to Water Contact in 6 year old boy with Aquagenic Urticaria

Angioedema in childhood: with or without urticaria

Aquagenic urticaria successfully treated with UVB-311

Assessing Post-Earthquake Living Conditions and Quality of Life in Chronic Spontaneous Urticaria Patients: Container houses vs. pre-existing buildings

Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Association between Acinetobacter baumannii-derived extracellular vesicles and chronic urticaria

Association between long-term PM2.5 exposure and risk of Urticaria and Allergic rhinitis in children: A nationwide longitudinal cohort study

Association of Antinuclear Antibodies with Different Phenotypes of Chronic Urticaria

Autoimune Chronic Urticaria Preceeding Sisitemic Lupus Erythematous

Automation of the Pooled Donor Basophil Activation Test for Chronic Urticaria using the Hamilton STAR: Enhancing Efficiency over the Manual Assay

Barzolvolimab Significantly Improves Angioedema in Patients with Chronic Spontaneous Urticaria (CSU): Results from a Phase 2 Trial

Beneficial role of Psychotherapeutic Interventions in Managing Chronic Spontaneous Urticaria Refractory to Omalizumab – A Case Study

Benralizumab in Omalizumab refractory chronic spontaneous urticaria – A Case Series of 4 Patients in Portugal

Beyond the Rash: How Omalizumab Shapes Mental Health Outcomes in Chronic Spontaneous Urticaria

Biomarkers in chronic spontaneous urticaria

Characterization of pathomechanisms of acute and chronic spontaneous urticaria

Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience

Cholinergic Urticaria – Negative Diagnostic Workup in a Patient with Typical History and Presentation

Cholinergic urticaria treated with dupilumab

Chronic Idiopathic Urticaria with the presence of Helicobacter pylori infection-clinical and laboratory data correlation

Chronic Spontaneous Urticaria Patients in Latvia: Epidemiological and Clinical Characteristics

Chronic Urticaria Activity in Patients Treated with Omalizumab at Bellvitge University Hospital (HUB)

Chronic Urticaria in Adolescence – An unusual association

Chronic Urticaria in Childhood: time for a review

Chronic spontaneous urticaria in Japan: real-world prevalence, treatments and healthcare resource utilisation based on a health insurance database

Chronic spontaneous urticaria in children: Series of 10 cases

Chronic spontaneous urticaria with wheals, angioedema, or both: Differences in clinical characteristics, biomarkers and treatment response

Chronic urticaria across the ages: clinical features, comorbidities, and treatment response

Cleanses and Questionable Information: A Content Analysis of Urticaria on TikTok™

Clinical Characteristics and Natural Course of Children with Dermographic Urticaria

Clinical Characteristics and Natural Course of Chronic Inducible Urticaria in a Pediatric Cohort

Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency

Clinical aspects of chronic urticaria

Clinical, Laboratory and Prognostic Evaluation of Antinuclear Antibody Positive and Negative Children with Chronic Urticaria

Clinical-laboratory evaluation of children with chronic urticaria

Comparable Efficacy and Pharmacodynamic Results of CT-P39 to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria

Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria

Comparison of Component Resolved Diagnosis (CRD) with skin prick test in respiratory allergy [36 cases] and Significance of CRD in Anaphylaxis [8 cases] & Chronic Urticaria with/ without Angioedema [16 cases]

Comparison of baseline clinical characteristics of chronic spontaneous urticaria patients receiving omalizumab, with and without concomitant angioedema

Comprehensive study on clinical characteristics of acute urticaria

Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Contact Urticaria due to Pimecrolimus

Correlation of chronic urticaria and angioedema with the presence of Helicobacter pylori infection

Cost Of Illness Analysis of Chronic Urticaria in 5 Latin American Countries: Diagnostic and Therapeutic Expenses

Cruciferous Vegetables and Food Allergy: A Case Study on Steamed Broccoli-Induced Urticaria

Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience

Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients

Diagnosis of inducible urticaria with the recommended tools

Diet modification recommendation for Chronic Spontaneous Urticaria patients -Albanian Allergists approach

Do air pollution and weather affect chronic urticaria attack frequency?

Dupilumab Improves Urticaria Activity, Health-Related Quality of Life, and Disease Perception and Severity in Patients with CSU: Results From the LIBERTY-CSU CUPID A Study

Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom

Efficacy and safety of switching to bilastine, a histamine H1 receptor antagonist, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a phase IV, multicenter, open-label, randomized, parallel-group comparative controlled trial

Efficacy and safety of therapy with omalizumab in children with chronic spontaneous urticaria

Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria

Efficacy of Re-treatment with Omalizumab in Adults with Chronic Spontaneous Urticaria who Relapsed after Treatment Withdrawal

Emerging treatments for chronic urticaria

Epidemiological data of patients with cold urticaria in Astana, the Republic of Kazakhstan

Evaluation of Real-World Mental Health and Sleep Outcomes Over Time in US Patients With Chronic Spontaneous Urticaria

Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria

From acute Urticaria to Anaphylaxis: A Case Presentation

Gain-of-function mutations of human MRGPRX2 in the Chronic spontaneous urticaria

Hidden parasitic causes in chronic spontaneous urticaria

Hives and hidden codes: detection of miRNA in chronic spontaneous urticaria patients – pilot study

How can we improve the approach to treating chronic urticaria in children?

IgE and Eosinophils levels may predict Successful Omalizumab withdrawal in chronic spontaneous urticaria

IgE anti-TPO; from acute to chronic urticaria

IgG and IgE autoantibodies in chronic spontaneous urticaria

Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Increased eosinophil-derived neurotoxin levels in serum of chronic spontaneous urticaria patients

Initial Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H1-Antihistamine Treatment

Investigation of Platelet Parameters during High Activity Urticaria and Vitamin D Level Significance

Knowledge and satisfaction about the use of Patient Reported Outcomes Measures (PROMs) by patients with chronic urticaria

Knowledge, attitudes and practice patterns in chronic spontaneous urticaria management among Italian General Practitioners: Baseline data from the BRIDGE implementation science study

LAD2 Mast Cell Activation Test in Chronic Spontaneous Urticaria

Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic

Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies

MOLECULAR IgE SENSITIZATION PROFILE IN A PATIENT WITH ADULT ATOPIC DERMATITIS AND CHRONIC URTICARIA SYNDROME TO FOODS

MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Management chronic urticaria in children

Management of Chronic Spontaneous Urticaria and Atopic Dermatitis with Omalizumab: A Case Report Highlighting Efficacy and Emerging Challenges

Management of beta-lactam induced urticaria

Mast cell mediated angioedema without wheals: Is It urticaria or not?

Minimal persistent inflammation in chronic spontaneous urticaria patients with clinical remission

New players in chronic urticaria

Next generation sequencing analysis in H1-antihistamine-refractory chronic spontaneous urticaria

PECU: A Multicenter Study on Pediatric Patients with Cold-Induced Urticaria

Patient-Centered Approaches and the Role of Bilastine in long-term Urticaria Management

Pediatric Hemophilia Patient: Successful Desensitization for Drug-Induced Fixed Urticaria with Prothrombin Complex Concentrate

Phenotypic Clusters of Patients with Severe Chronic Spontaneous Urticaria

Physicians’ prescribing patterns and perceptions of treatments for chronic spontaneous urticaria: Real world data from Urticaria Voices

Predicting Responses to Omalizumab in Antihistamine-Refractory Chronic Urticaria

Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients

Protein induced contact urticaria

Quality of life of families with children suffering from chronic urticaria

Rare cause of urticaria

Real World Web Survey on the Burden of Urticaria

Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria

Recall urticaria to dalteparin sodium in a patient with previous systemic reaction to nadroparin calcium

Reduction in Weekly Urticaria Activity Score (UAS7) With Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 Dose-Ranging Study

Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Remibrutinib improves chronic spontaneous urticaria independent of baseline immunoglobulin E levels in the phase 3 REMIX studies

Retrospective Evaluation of Acute Urticaria Patients Presenting to Pediatric Emergency Department

Rilzabrutinib Reduces IgG Anti-Thyroid Peroxidase (anti-TPO), Soluble Mas-Related G Protein-Coupled Receptor X2 (sMRGPRX2) and Eosinophils at 12 Weeks in Patients With Chronic Spontaneous Urticaria

Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis

Safety and effectiveness of Omalizumab for Cold Urticaria in pediatric age

Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series

Successful administration of omalizumab following anaphylaxis in a patient with chronic idiophatic urticaria

Systemic Histaminergic Findings in Children with Chronic Urticaria

Taking a closer look to the first EMA-approved omalizumab biosimilar in Chronic Spontaneous Urticaria

The BEACON Study: A Phase 1b/2a, Dose Escalation Study of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of the c-Kit Mab Briquilimab in Adults with symptomatic Chronic Spontaneous Urticaria (CSU)

The UCARE Study on the Prevalence of Sleep Disorders and Nighttime Bruxism in People with Chronic Urticaria

The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients

The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study

The challenge of chronic urticaria management

The characteristics of Chronic Inducible Urticaria in Cape Town, South Africa

The first certified urticaria center of the UCARE network in the Republic of Kazakhstan

The impact of cold urticaria therapy on the threshold for reactivity

The perfect storm: a case of cofactor associated LTP allergy coexisting with cholinergic and vibratory urticaria

Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?

Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare

Treatment of refractory urticaria in children

Treatment with Barzolvolimab Leads to Sustained Improvement in Angioedema in Chronic Spontaneous Urticaria (CSU) patients: Results from 52 Weeks of Treatment

Update on chronic inducible urticaria

Updates in urticaria guidelines

Urticaria Outpatient Clinic: one year experience of a Portuguese center

Urticaria and Angioedema

Urticaria in the context of treatment with trimethoprim/sulfamethoxazole due to trimethoprim sensitization

Urticaria therapy: the past and the future

What to examine when you consider chronic urticaria

What’s new in chronic urticaria management?

Features of chronic spontaneous urticaria in patients with atopic comorbidities: Results from CURE, the chronic urticaria registry

Impact of chronic inducible urticaria (CIndU) on patients’ health-related quality of life: Results from Urticaria Voices study

Linguistic Adaptation of Urticaria Activity Score Over 7 Days (UAS7) to Latvian: Evaluating Disease Activity in Adult Patients with Chronic Spontaneous Urticaria in Latvia

Paradoxical urticaria to H1-antihistamines in a patient with chronic spontaneous urticaria

The Urticaria Voices study: Experiences and unmet needs of patients with chronic inducible urticaria (CIndU)

Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan

Urticaria exacerbations in children with chronic urticaria receiving COVID-19 vaccination

Worldwide experiences and unmet needs of patients with chronic spontaneous urticaria and treating physicians: The Urticaria Voices study

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website